The Smith & Nephew plc (LON:SN) Given "Sell" Rating at Citigroup Inc

Accern also gave media headlines about the medical equipment provider an impact score of 47.0158549719567 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Smith & Nephew SNATS (NYSE SNN) traded up 0.20% on Friday, reaching $35.06. The stock's 50 day moving average is GBX 1,348.54 and its 200 day moving average is GBX 1,254.86. Smith & Nephew SNATS, Inc. has a 12-month low of $26.97 and a 12-month high of $35.85. The legal version of this news story can be viewed at https://www.chaffeybreeze.com/2017/08/12/bbt-corp-cuts-position-in-smith-nephew-snats-inc-snn-updated-updated.html.

A number of institutional investors have recently modified their holdings of SNN.

Smith & Nephew plc had its "hold" rating reaffirmed by analysts at Deutsche Bank AG.

Separately, Zacks Investment Research downgraded Smith & Nephew SNATS from a buy rating to a hold rating in a research report on Tuesday, June 27th. Paloma Partners Management Co bought a new stake in shares of Smith & Nephew SNATS during the first quarter valued at approximately $200,000. Four analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company.

Smith & Nephew plc is a medical technology company.

Smith Nephew PLC has a 52 week low of 1,064.91GBX and a 52 week high of 1,390.00GBX with a P/E ratio of 13.62 The company's market cap is now 0 GBX.

7/10/2017 - Smith & Nephew plc had its "sell" rating reaffirmed by analysts at Citigroup Inc. The stock has a consensus rating of "Buy" and a consensus price target of $38.00. If you are accessing this report on another website, it was illegally copied and republished in violation of United States & worldwide copyright & trademark legislation. Geneva Advisors LLC now owns 34,027 shares of the medical equipment provider's stock valued at $1,052,000 after buying an additional 1,387 shares during the last quarter. Bahl & Gaynor Inc. now owns 21,440 shares of the medical equipment provider's stock worth $645,000 after buying an additional 60 shares during the last quarter. RMB Capital Management LLC acquired a new stake in shares of Smith & Nephew SNATS during the first quarter valued at $219,000. World Asset Management Inc now owns 27,656 shares of the medical equipment provider's stock valued at $855,000 after buying an additional 285 shares in the last quarter.

Several hedge funds have recently added to or reduced their stakes in the company. The stock of Smith & Nephew plc (ADR) (NYSE:SNN) earned "Hold" rating by Berenberg on Thursday, October 6. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services.

Altre Notizie